deltatrials
Completed PHASE4 NCT00442975

Response of Older Adults to Influenza Vaccination With Regard to Cytomegalovirus (CMV) Status

A Phase IV, Single Group Study to Evaluate the Immune Response to Licensed Seasonal Influenza Vaccine and Relationship of This to Cytomegalovirus-associated Immunosenescence in UK Older Adults Aged 50-80 Years

Sponsor: Public Health England

Conditions Influenza
Interventions Fluarix
Updated 6 times since 2017 Last updated: Aug 28, 2018 Started: Mar 31, 2007 Completion: Sep 30, 2007

A PHASE4 clinical study on Influenza, this trial is completed. The trial is conducted by Public Health England and has accumulated 6 data snapshots since 2007. Infectious disease trials contribute critical data for public health response and treatment development.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  4. Sep 2018 — Jan 2021 [monthly]

    Completed PHASE4

  5. Jun 2018 — Sep 2018 [monthly]

    Completed PHASE4

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE4

    First recorded

Mar 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Public Health England
  • Royal Free and University College Medical School
Data source: Public Health England

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Stevenage, United Kingdom